CatalystPit

INCYINCYTE CORP

NASDAQ · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Last close $121.35 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorConsumer Cyclical
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Market cap$24.60B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-05 · Heeson Lee (EVP, Head of Incyte Intl) · OTHER
  • 2026-10-02 · BAKER BROS. ADVISORS LP (Director) · OTHER
  • 2026-10-02 · HARRIGAN EDMUND (Director) · OTHER
  • 2026-10-02 · Clancy Paul J (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders927
Shares held246,765,068
Value$25.34B
Percent of shares outstanding121.74%
As of quarter end2026-06-30
RECENT NEWS
  • What to Expect From Incyte’s Next Quarterly Earnings Report
  • H.C. Wainwright raises Incyte price target on Atebrioz approval
  • Mirum and Incyte gain approval of zilurgisertib for rare bone disorder
  • How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
  • How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS